A partnership built on complementary expertise

The collaboration, officially formalised in July 2024, combines AlgenScribe’s genome-editing technology with complementary innovations developed at the Max Delbrück Center, supported by Ascenion’s technology transfer expertise.

Together, the partners aim to accelerate research and contribute to the development of future cell therapies for genetically determined diseases.

BioFIT as the starting point

While partnerships often take months to develop, they usually begin with one essential ingredient: the right introduction.
For this collaboration, that first connection happened during BioFIT.

Dr. Sigrid Scheek, Technology Manager at Ascenion, recalls:

“We are delighted that we were able to initiate this cooperation at the French partnering event BioFIT in Marseille.”

For AlgenScribe, BioFIT also opened the door to new international opportunities.

As CEO Frédéric Zampatti explains:

“BioFIT enabled us to connect with numerous stakeholders and establish two scientific collaborations, including our first international partnership with the Max Delbrück Center in Berlin.”

Turning meetings into collaborations

Every year, BioFIT brings together technology transfer offices, research organisations, biotech and pharma companies, investors and innovation stakeholders from across Europe and beyond.

The objective is simple: create the conditions for meaningful discussions that can evolve into research collaborations, licensing agreements, investment opportunities and strategic partnerships.

The collaboration between AlgenScribe, Max Delbrück Center and Ascenion illustrates how a conversation initiated during the event can develop into a project with long-term scientific and medical ambitions.

Meet your future partners at BioFIT 2026

BioFIT returns on  December 10th and 11th, 2026 in Marseille, co-organised with MedFIT.

Whether you are seeking research collaborations, licensing opportunities, investors or strategic partners, BioFIT provides a dedicated environment to meet the people who can help move your innovation forward.

Join key BioFIT 2025 sponsors such as GENFIT to take advantage of the following opportunities:

• Identify your organisation with the main partnering event in Europe dedicated to technology transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
• Highlight your interest in early-stage innovation
• Present your ideas and technologies to key innovation players in Life Sciences
• Enhance your visibility on an international scale and be recognised as a key innovative player
• Demonstrate your expertise using specific communication tools

D4A represents almost 90% of the companies operating on this market.

In 2025, all our 32 companies are accredited according to quality systems (ISO 9001 at least).

Our Database:

D4A database offers more than 3300 animal health diagnostics available on our website.

As an exhibitor, your organisation will be featured on BioFIT’s official website, on the online partnering platform and in the printed programme available to all participants.

The exhibition area is a central hub of the event, offering maximum visibility and engagement.
Whether you’re a start-up, TTO, research institute or biotech/pharma company, take this opportunity to be seen and connect with those shaping the future of Life Sciences!

Highlights of their offerings:

• UGent Cross-Health Platform: A unique initiative that fosters multidisciplinary research and innovation activities, spanning across species (human, companion animals, livestock) and integrating diverse technologies such as medtech, AI, medicinal chemistry, and tissue engineering. This platform is at the forefront of creating novel applications for animal health.
• Collaborative Expertise: They bring together researchers with complementary skills, enabling breakthroughs in health applications that benefit multiple species. Their work spans discovery and applied research, pushing the boundaries of what’s possible in animal health.

Join Provaxs to co-create the future of animal health through cutting-edge research and technology transfer.

Join key BioFIT 2025 sponsors such as Boehringer Ingelheim to take advantage of the following opportunities:

• Identify your organisation with the main partnering event in Europe dedicated to technology transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
• Highlight your interest in early-stage innovation
• Present your ideas and technologies to key innovation players in Life Sciences
• Enhance your visibility on an international scale and be recognised as a key innovative player
• Demonstrate your expertise using specific communication tools

Join key BioFIT 2025 sponsors such as Boehringer Ingelheim and X’PROCHEM to take advantage of the following opportunities:

• Identify your organisation with the main partnering event in Europe dedicated to technology transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
• Highlight your interest in early-stage innovation
• Present your ideas and technologies to key innovation players in Life Sciences
• Enhance your visibility on an international scale and be recognised as a key innovative player
• Demonstrate your expertise using specific communication tools

3 pitch categories to take your project to the next level:

Why exhibit at BioFIT 2025?

Take your innovation to the next level by securing a prime space in our exhibition area and:
🔬 Showcase your innovation: Present your latest advances to key industry stakeholders
🤝 Connect with decision makers from biotech, pharma and beyond
🚀 Increase your visibility: Raise your brand with top investors and potential partners
💡 Generate leads: Meet potential clients and collaborators in a dynamic business environment